Allogeneic placental mesenchymal cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic placental mesenchymal cells, covering 2024-11-07 to 2024-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery [Phase 1, Phase 2]